Literature DB >> 27219491

Cholinergic interneurons in the Q140 knockin mouse model of Huntington's disease: Reductions in dendritic branching and thalamostriatal input.

Yun-Ping Deng1, Anton Reiner2.   

Abstract

We have previously found that thalamostriatal axodendritic terminals are reduced as early as 1 month of age in heterozygous Q140 HD mice (Deng et al. [] Neurobiol Dis 60:89-107). Because cholinergic interneurons are a major target of thalamic axodendritic terminals, we examined the VGLUT2-immunolabeled thalamic input to striatal cholinergic interneurons in heterozygous Q140 males at 1 and 4 months of age, using choline acetyltransferase (ChAT) immunolabeling to identify cholinergic interneurons. Although blinded neuron counts showed that ChAT+ perikarya were in normal abundance in Q140 mice, size measurements indicated that they were significantly smaller. Sholl analysis further revealed the dendrites of Q140 ChAT+ interneurons were significantly fewer and shorter. Consistent with the light microscopic data, ultrastructural analysis showed that the number of ChAT+ dendritic profiles per unit area of striatum was significantly decreased in Q140 striata, as was the abundance of VGLUT2+ axodendritic terminals making synaptic contact with ChAT+ dendrites per unit area of striatum. The density of thalamic terminals along individual cholinergic dendrites was, however, largely unaltered, indicating that the reduction in the areal striatal density of axodendritic thalamic terminals on cholinergic neurons was due to their dendritic territory loss. These results show that the abundance of thalamic input to individual striatal cholinergic interneurons is reduced early in the life span of Q140 mice, raising the possibility that this may occur in human HD as well. Because cholinergic interneurons differentially affect striatal direct vs. indirect pathway spiny projection neurons, their reduced thalamic excitatory drive may contribute to early abnormalities in movement in HD. J. Comp. Neurol. 524:3518-3529, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  AB_2301731; AB_90650; Huntington's disease; cholinergic interneurons; corticostriatal; pathology; premanifest; striatum; thalamostriatal

Mesh:

Substances:

Year:  2016        PMID: 27219491      PMCID: PMC5050058          DOI: 10.1002/cne.24013

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  81 in total

1.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

2.  Relation of pontine choline acetyltransferase immunoreactive neurons with cells which increase discharge during REM sleep.

Authors:  P J Shiromani; D M Armstrong; G Bruce; L B Hersh; P M Groves; J C Gillin
Journal:  Brain Res Bull       Date:  1987-03       Impact factor: 4.077

3.  Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.

Authors:  C M Kipps; A J Duggins; N Mahant; L Gomes; J Ashburner; E A McCusker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

4.  In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.

Authors:  Myria Petrou; Kirk A Frey; Michael R Kilbourn; Peter J H Scott; David M Raffel; Nicolaas I Bohnen; Martijn L T M Müller; Roger L Albin; Robert A Koeppe
Journal:  J Nucl Med       Date:  2014-01-30       Impact factor: 10.057

5.  Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.

Authors:  Sarah A J Reading; Michael A Yassa; Arnold Bakker; Adam C Dziorny; Lisa M Gourley; Venu Yallapragada; Adam Rosenblatt; Russell L Margolis; Elizabeth H Aylward; Jason Brandt; Susumu Mori; Peter van Zijl; Susan S Bassett; Christopher A Ross
Journal:  Psychiatry Res       Date:  2005-09-30       Impact factor: 3.222

6.  Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease.

Authors:  H Heinsen; U Rüb; M Bauer; G Ulmar; B Bethke; M Schüler; F Böcker; W Eisenmenger; M Götz; H Korr; C Schmitz
Journal:  Acta Neuropathol       Date:  1999-06       Impact factor: 17.088

7.  Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

Authors:  S J Augood; R L Faull; P C Emson
Journal:  Ann Neurol       Date:  1997-08       Impact factor: 10.422

8.  Spatial organization of patch and matrix compartments in the rat striatum.

Authors:  M Desban; M L Kemel; J Glowinski; C Gauchy
Journal:  Neuroscience       Date:  1993-12       Impact factor: 3.590

9.  Confocal laser scanning microscopy and ultrastructural study of VGLUT2 thalamic input to striatal projection neurons in rats.

Authors:  Wanlong Lei; Yunping Deng; Bingbing Liu; Shuhua Mu; Natalie M Guley; Ting Wong; Anton Reiner
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

10.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

View more
  18 in total

1.  Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Authors:  Mark F Mehler; Jenna R Petronglo; Eduardo E Arteaga-Bracho; Maria E Gulinello; Michael L Winchester; Nandini Pichamoorthy; Stephen K Young; Christopher D DeJesus; Hifza Ishtiaq; Solen Gokhan; Aldrin E Molero
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

2.  Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.

Authors:  Anna Parievsky; Cindy Moore; Talia Kamdjou; Carlos Cepeda; Charles K Meshul; Michael S Levine
Journal:  Neurobiol Dis       Date:  2017-07-27       Impact factor: 5.996

3.  Three-Dimensional Spatial Analyses of Cholinergic Neuronal Distributions Across The Mouse Septum, Nucleus Basalis, Globus Pallidus, Nucleus Accumbens, and Caudate-Putamen.

Authors:  Andres Carrasco; Dorothy E Oorschot; Paolo Barzaghi; Jeffery R Wickens
Journal:  Neuroinformatics       Date:  2022-07-06

4.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

Review 5.  Disrupted striatal neuron inputs and outputs in Huntington's disease.

Authors:  Anton Reiner; Yun-Ping Deng
Journal:  CNS Neurosci Ther       Date:  2018-04       Impact factor: 5.243

6.  Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington's Disease Mutations.

Authors:  Sonia Malaiya; Marcia Cortes-Gutierrez; Brian R Herb; Sydney R Coffey; Samuel R W Legg; Jeffrey P Cantle; Carlo Colantuoni; Jeffrey B Carroll; Seth A Ament
Journal:  J Neurosci       Date:  2021-05-19       Impact factor: 6.167

Review 7.  Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Authors:  Claudia Rangel-Barajas; George V Rebec
Journal:  J Huntingtons Dis       Date:  2016-12-15

Review 8.  Targeting the Cholinergic System to Develop a Novel Therapy for Huntington's Disease.

Authors:  Gary X D'Souza; Henry J Waldvogel
Journal:  J Huntingtons Dis       Date:  2016-12-15

9.  Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington's Disease.

Authors:  Asami Tanimura; Sean Austin O Lim; Jose de Jesus Aceves Buendia; Joshua A Goldberg; D James Surmeier
Journal:  Front Syst Neurosci       Date:  2016-12-16

10.  Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.

Authors:  Yunping Deng; Hongbing Wang; Marion Joni; Radhika Sekhri; Anton Reiner
Journal:  J Comp Neurol       Date:  2020-09-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.